Our lab has previously shown that TG2 activity as determined by serotonylation of fibronectin (sFn) is elevated in serum of PAH patients as well as in serum and lungs of experimental rodent models of PH (5, 26). This evidence concerns the gene TGM2 and pulmonary arterial hypertension.